You just read:

Neurim Pharmaceuticals Grants Exeltis Marketing Rights for Paediatric Prolonged-Release Melatonin ("PedPRM") in Spain

News provided by

Neurim Pharmaceuticals

29 Mar, 2017, 09:00 ET